Lack of Rb and p53 Expression in a Case of CM2B4 Negative Merkel Cell Carcinoma In Situ Associated With Squamous Dysplasia
Journal of Cutaneous Pathology · 2026
DOI: 10.1111/cup.70073 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Cutaneous Pathology, 2026. Verfasst von Austinn C Miller und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Central Florida HCA Florida Healthcare Graduate Medical Education, Tallahassee, Florida, USA. Hauptthemen laut MEDLINE: Carcinoma, Merkel Cell, Tumor Suppressor Protein p53, Skin Neoplasms, Retinoblastoma Protein. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Merkel cell carcinoma (MCC) is a dermal neuroendocrine malignancy driven by inactivation of the tumor suppressors Rb and p53 either through Merkel cell polyomavirus (MCPyV) infection or ultraviolet (UV)‐induced mutations. Virus‐positive MCC exhibits pure neuroendocrine morphology, low UV‐induced mutational burden, retained Rb protein, and low p53 expression. Viral‐negative MCC includes pure neuroendocrine carcinomas and combined tumors with squamous and neuroendocrine components. These tumors typically exhibit loss of Rb expression and either overexpression of mutated p53 or a complete absence of p53. Intraepidermal, in situ MCC (MCCis) is a rare, primarily viral‐negative variant that often coexists with actinic keratosis (AK) and squamous cell carcinoma in situ (SCCis), supporting a UV‐driven pathogenesis. While MCCis is hypothesized as a potential precursor to select cases of combined MCC, its p53 and Rb expression remain largely uncharacterized. We report a CM2B4‐negative MCCis in an 87‐year‐old man associated with AK and SCCis. Compared to normal epidermis, AK and SCCis exhibited increased Rb and p53 expression, whereas MCCis demonstrated loss of expression of both tumor suppressors. These findings suggest that dual downregulation of Rb and p53 may drive select cases of MCCis in sun‐damaged skin.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Central Florida HCA Florida Healthcare Graduate Medical Education, Tallahassee, Florida, USA.
- Dermatology Associates of Tallahassee, Tallahassee, Florida, USA.
- Florida State University College of Medicine, Tallahassee, Florida, USA.
- Boston University School of Medicine, Boston, Massachusetts, USA.
- Inform Diagnostics, Needham, Massachusetts, USA.
ORCID-Profile: Austinn C Miller
Zitieren
APA
Miller, A. C., Rendon, E. D., Branscome, N., Padilla, P., Richardson, S., Dolson, D., & Schaffer, A. (2026). Lack of Rb and p53 Expression in a Case of CM2B4 Negative Merkel Cell Carcinoma In Situ Associated With Squamous Dysplasia. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.70073
Vancouver
Miller AC, Rendon ED, Branscome N, Padilla P, Richardson S, Dolson D, et al. Lack of Rb and p53 Expression in a Case of CM2B4 Negative Merkel Cell Carcinoma In Situ Associated With Squamous Dysplasia. Journal of Cutaneous Pathology. 2026. doi:10.1111/cup.70073
BibTeX
@article{Miller2026,
author = {Miller, Austinn C and Rendon, Eric Delgado and Branscome, Nathanial and Padilla, Pamela and Richardson, Stephen and Dolson, David and Schaffer, András},
title = {Lack of Rb and p53 Expression in a Case of CM2B4 Negative Merkel Cell Carcinoma In Situ Associated With Squamous Dysplasia},
journal = {Journal of Cutaneous Pathology},
year = {2026},
doi = {10.1111/cup.70073}
}
EUVIMED